Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib might be used to treat hair loss.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Upadacitinib improved multiple immune-related conditions in one patient.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

The compound zishenqing formula is effective and safe for treating mild to moderate systemic lupus erythematosus.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Tofacitinib treatment is used for teenagers with alopecia areata.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Rituximab may cause skin issues, but baricitinib can help improve them.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

TAK-279 effectively reduces psoriasis symptoms and is safe.